INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE Journal

publication venue for

Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review). 43:15-25. 2019
Formulation and characterization of EGCG for the treatment of superficial bladder cancer. 40:329-336. 2017
Clinical implications of the growth-suppressive effects of chlorhexidine at low and high concentrations on human gingival fibroblasts and changes in morphology. 37:1594-1600. 2016
The plasminogen activation system in periodontal tissue (Review). 33:763-768. 2014
Unusual clotting dynamics of plasma supplemented with iron(III). 33:367-372. 2014
Analysis of the inhibition of PAI-1 by metal theaflavin complexes and their degradation products. 31:1153-1158. 2013
Plasminogen activator inhibitor-1 in kidney pathology (Review). 31:503-510. 2013
A study of the anti-diabetic agents of camel milk. 30:585-592. 2012
Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structure. 29:61-64. 2012
Diverse inhibition of plasminogen activator inhibitor type 1 by theaflavins of black tea. 27:525-529. 2011
Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total blood loss. 26:501-504. 2010
Theaflavin digallate inactivates plasminogen activator inhibitor: Could tea help in Alzheimer's disease and obesity?. 26:45-50. 2010
The mechanism of atopic march may be the ‘social’ event of cells and molecules (Review). 26. 2010
Human platelet 12-lipoxygenase: Naturally occurring Q261/R261 variants and N544L mutant show altered activity but unaffected substrate binding and membrane association behavior. 24:759-764. 2009
VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form. 23:57-63. 2009
PAI-1 induces cell detachment, downregulates nucleophosmin (B23) and fortilin (TCTP) in LnCAP prostate cancer cells. 20:11-20. 2007
A molecular cross-talk cell signaling circuitry regulates tumor resistance and metastasis: identification of novel therapeutic small molecules that reverse these phenotypes 2009
Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmla-associated transcription factor target genes in melanoma 2009
Determining whether curcumin degradation/condensation is actually bioactivation (Review) 2016
Complex interaction between the immune system and adipose tissue (Review) 2014
Can inactivators of plasminogen activator inhibitor alleviate the burden of obesity and diabetes? (Review) 2012

category

MEDICINE, RESEARCH & EXPERIMENTAL Category

International Standard Serial Number (ISSN)

1107-3756

Electronic International Standard Serial Number (EISSN)

1791-244X

journal abbreviation

INT J MOL MED